WealthShield Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

WealthShield Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-91	Closed	-$2.53K	–	567
2025 Q3	$2.53K	Hold	91	–	–	﹤0.01%	546
2025 Q2	$2.22K	Hold	91	–	–	﹤0.01%	540
2025 Q1	$1.89K	Hold	91	–	–	﹤0.01%	526
2024 Q4	$2.14K	Buy	+91	New	+$2.24K	﹤0.01%	481
2021 Q3	–	Sell	-352	Closed	-$33K	–	269
2021 Q2	$33K	Sell	352 -115	-25%	-$9.78K	0.01%	559
2021 Q1	$41K	Buy	+467	New	+$46.3K	0.01%	490

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

WealthShield Partners's ARKG Position: Q4 2025 in Review

WealthShield Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 91 shares — an estimated $2.53K sold.

WealthShield Partners first reported a position in ARKG in Q1 2021 and held it in 6 quarters. The position peaked at $41K in Q1 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

WealthShield Partners reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
WealthShield Partners sold 91 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $2.53K.
WealthShield Partners first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 6 quarters.
WealthShield Partners's ARK Genomic Revolution ETF position peaked at $41K in Q1 2021.
239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on WealthShield Partners's 13F filing for Q4 2025, filed 3 Feb 2026.